Nanoparticulate delivery system for insulin: Design, characterization and in vitro/in vivo bioactivity
Authors:
- Catarina Pinto ReisCRCatarina Pinto Reis
- António J. RibeiroARAntónio J. Ribeiro
- Simone HoungSHSimone Houng
- Francisco VeigaFrancisco Veiga
- Ronald J. NeufeldRNRonald J. Neufeld
- 1 April 2007
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 30 (5) , 392-397
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Oral delivery of insulin associated to polymeric nanoparticles in diabetic ratsJournal of Controlled Release, 2007
- Emerging role of protein kinase B/Akt signaling in pancreatic β-cell mass and functionThe International Journal of Biochemistry & Cell Biology, 2006
- Design of insulin-loaded alginate nanoparticles: Influence of the calcium ion on polymer gel matrix propertiesChemical Industry and Chemical Engineering Quarterly, 2006
- Cross-linked alginate–gelatine beads: a new matrix for controlled release of pindololJournal of Controlled Release, 2004
- Formulation pH modulates the interaction of insulin with chitosan nanoparticlesJournal of Pharmaceutical Sciences, 2002
- Spray-dried insulin particles retain biological activity in rapid in-vitro assayJournal of Pharmacy and Pharmacology, 2001
- Evaluation of protein release from chitosan-aginate microcapsules produced using external or internal gelationJournal of Microencapsulation, 2001
- Stabilization of insulin by alkylmaltosides. B. Oral absorption in vivo in ratsInternational Journal of Pharmaceutics, 1996
- Human Insulin: Basic Sciences to Therapeutic UsesDrug Development and Industrial Pharmacy, 1996
- Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patchesJournal of Controlled Release, 1990